0 followers
By leveraging their immunology expertise, HCW is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.
Hing C. Wong
Kura Oncology
20 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Cabaletta Bio
1 follower
Janux Therapeutics
1 follower
Matica Biotechnology
1 follower
Explore companies